Grown Rogue International (GRUSF) Total Non-Current Liabilities (2009 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Total Non-Current Liabilities of $2.9 million in Q1 2026, down 3.0% quarter-over-quarter from $3.0 million in Q4 2025, and down 100.0% on a YoY basis from $28185405389.2 billion in Q1 2025.
Grown Rogue International (GRUSF) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Grown Rogue International's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $2.9 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 100.0% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (down 100.0% YoY), while the FY2025 annual figure was $3.0 million, down 5.41% from the prior year.
- Total Non-Current Liabilities was $2.9 million for Q1 2026 at Grown Rogue International, down from $3.0 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $28159893000.0 billion in Q1 2025 to a low of -$4.9 million in Q4 2023.
- Historically, Total Non-Current Liabilities has averaged $5260453667.2 billion across 5 years, with a median of $3.0 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities plunged 780.32% in 2023, then surged 1652.92% in 2025.
- A 5-year view of Total Non-Current Liabilities shows it stood at $715461.0 in 2022, then surged by 894.27% to $7.1 million in 2023, then plunged by 102.72% to -$193195.5 in 2024, then soared by 1652.92% to $3.0 million in 2025, then retreated by 3.0% to $2.9 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $2.9 million (Q1 2026), $3.0 million (Q4 2025), and $23005.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | Grown Rogue International | - | - | 3.96 Mn | 2.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.91 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 23,005.21 Bn |
| Jun 30, 2025 | 19,184,167,000.00 Bn |
| Mar 31, 2025 | 28,159,893,000.00 Bn |
| Dec 31, 2024 | -193,195.51 |
| Dec 31, 2023 | 7.11 Mn |
| Oct 31, 2023 | -4.87 Mn |
| Oct 31, 2022 | 715,461.00 |
| Oct 31, 2021 | 1.23 Mn |
| Oct 31, 2020 | 68,994.00 |
| May 31, 2018 | -583,997.90 |
| Feb 28, 2018 | -595,244.05 |
| Nov 30, 2017 | -597,802.38 |
| Aug 31, 2017 | -170,845.96 |
| May 31, 2017 | -1.07 Mn |
| Feb 28, 2017 | 20.75 Mn |
| Nov 30, 2016 | 20.72 Mn |
| Aug 31, 2016 | -1.35 Mn |
| May 31, 2016 | -25.54 Mn |